logo
Select company
Select metric
8.03Enterprise Value over EBIT
VS
Market
90
Sector
88
Industry
73
History
-
$ 4.01Close
$ 1.25 - $ 4.32 52-Week Range
Ticker Information

Ticker

BDTX

Company Name

BLACK DIAMOND THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BLACK DIAMOND THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDTX - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ 14.44M$ 115.97M8.03
3/31/2025$ 5.09M$ 18.15M3.56
12/31/2024$ -69.68M$ 89.18M0
9/30/2024$ -73.1M$ 179.32M0
6/30/2024$ -80.55M$ 269.7M0
3/31/2024$ -79.79M$ 374.83M0
12/31/2023$ -82.44M$ 160.63M0
9/30/2023$ -84.11M$ 62.83M0
6/30/2023$ -82.76M$ 152.41M0
3/31/2023$ -86.54M$ 50.69M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BLACK DIAMOND THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, BLACK DIAMOND THERAPEUTICS INC's average EV/EBIT has been 5.8.
  • The median EV/EBIT for BLACK DIAMOND THERAPEUTICS INC during this period was 5.8
  • BLACK DIAMOND THERAPEUTICS INC reached its highest EV/EBIT over the past 5 years at 8.03.
  • The lowest EV/EBIT recorded by BLACK DIAMOND THERAPEUTICS INC in the same timeframe 3.56

BLACK DIAMOND THERAPEUTICS INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
PLX : PROTALIX BIOTHERAPEUTICS INC 11.83THTX : THERATECHNOLOGIES INC 28.74SGMO : SANGAMO THERAPEUTICS INC -ALEC : ALECTOR INC -CSBR : CHAMPIONS ONCOLOGY INC 38.27ENTA : ENANTA PHARMACEUTICALS INC -SPRO : SPERO THERAPEUTICS INC -AGEN : AGENUS INC -CELU : CELULARITY INC -IVVD : INVIVYD INC -

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for BLACK DIAMOND THERAPEUTICS INC is calculated as follows: EV [ $ 1.17B ] / EBIT [ $ -54.5M ]
(=) EV/EBIT [ 0 ]

BDTX - Enterprise Value over EBIT, Last 5 years

3.56

Minimum

Mar 31, 2025

8.03

Maximum

Jun 30, 2025

5.8

Average

5.8

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32